REVB Revelation Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: REVB

Price (delayed)

$0.9344

Market cap

$3.72M

P/E Ratio

0.21

Dividend/share

N/A

EPS

$4.37

Enterprise value

-$7.02M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 7
Relative Valuation: Rel. Valuation: 48
Relative Profitability: Rel. Profitability: 1
Highlights
The debt has contracted by 2.5% from the previous quarter
REVB's equity has surged by 163% year-on-year but it is down by 22% since the previous quarter
The EPS has surged by 119% since the previous quarter but it has dropped by 97% year-on-year
The net income is down by 27% YoY and by 9% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.revbiosciences.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of REVB

REVB stock price

How has the Revelation Biosciences stock price performed over time
Intraday
-4.65%
1 week
1.57%
1 month
-14.28%
1 year
-84.11%
YTD
-70.8%
QTD
-9.28%

Financial performance

How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.27M
Net income
-$10.75M
Gross margin
N/A
Net margin
N/A
REVB's operating income is down by 39% YoY and by 12% from the previous quarter
The net income is down by 27% YoY and by 9% QoQ

Price vs fundamentals

How does REVB's price correlate with its fundamentals

Growth

What is Revelation Biosciences's growth rate over time

Valuation

What is Revelation Biosciences stock price valuation
P/E
0.21
P/B
0.36
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 119% since the previous quarter but it has dropped by 97% year-on-year
REVB's equity has surged by 163% year-on-year but it is down by 22% since the previous quarter
The price to book (P/B) is 83% lower than the 5-year quarterly average of 2.2 and 5% lower than the last 4 quarters average of 0.4

Efficiency

How efficient is Revelation Biosciences business performance
REVB's return on equity is up by 46% year-on-year and by 24% since the previous quarter
The company's return on assets rose by 28% YoY and by 23% QoQ

Dividends

What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for REVB.

Financial health

How did Revelation Biosciences financials performed over time
The company's total assets has surged by 132% YoY but it fell by 17% QoQ
The quick ratio has soared by 85% year-on-year but it is down by 39% since the previous quarter
The debt is 93% less than the equity
REVB's equity has surged by 163% year-on-year but it is down by 22% since the previous quarter
REVB's debt to equity is up by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.